Type 2 diabetes with peripheral neuropathy. Diabetes mellitus due to underlying condition with diabetic nephropathy
Conditions
Interventions
Intervention 1: Intervention group: Type 2 diabetic patients with peripheral neuropathy in the intervention group receive 300 mg of gabapentin and complete 10 sessions of physiotherapy. The control gr
Sponsors
Zabol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Informed Consent Peripheral neuropathy and type two diabetes 30 to 70 years Patients should only use gabapentin as a treatment for neuropathy.
Exclusion criteria
Exclusion criteria: Having skin lesions or swelling that disrupts nerve conduction. Infected with neuropathies related to malnutrition and alcoholic neuropathy. To undergo the amputation. Combining Gabapentin with Other Pain Medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in symptoms of peripheral neuropathy. Timepoint: Before and after intervention (0-21 days). Method of measurement: Pain level, examination of the neuromuscular strip. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum concentration of TNF-a, picograms/microliter. Timepoint: Before and after intervention. Method of measurement: ELISA.;C-Reactive Protein. Timepoint: Before and after intervention. Method of measurement: Nephelometry method.;Visual analogical pain scores. Timepoint: Numerical. Method of measurement: Of 0 (least) to 10 (most) pain. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactJavad Poursamimi
Zabol University of Medical Sciences
Outcome results
None listed